An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD

NCT02228655 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to recruit patients meeting eligibilty criteria.

Conditions

Anemia in Chronic Kidney Disease

Interventions

DRUG: FMX-8

Sponsor

FerruMax Pharmaceuticals, Inc.